ERBB2 and breast carcinoma: This distribution differs from large study series in female breast carcinoma [8,9,24,25], which reported much lower frequencies of luminal A subtype (51 to 69%) but significantly higher frequencies of basal-like (12 to 21%) and HER2+/ER- (7 to 12%) subtypes.